Bristol-Myers Squibb BMY

$60.72

−$0.44 (-0.71%)

Market open · Sep 24, 1:10 pm ET

After hours $61.34 +0.31%

Open$61.21

Prev close$61.15

Day range$60.60 – $61.57

Volume4.16M

Market cap$124.02B

P/E (TTM)13.4

Dividend yield4.13%

Piper Sandler Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Raises Target Price to $82 Market news · 16 Sep 2026
RBC Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $64 Market news · 15 Sep 2026
HSBC Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $65 Market news · 10 Sep 2026
J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $73 Market news · 5 Aug 2026
Argus Research Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Announces Target Price $75 Market news · 5 Aug 2026
Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Raises Target Price to $70 Market news · 3 Aug 2026
BofA Securities Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $71 Market news · 3 Aug 2026
Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating Market news · 21 Aug 2026
UBS Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $80 Market news · 20 Aug 2026
Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $70 Market news · 14 Aug 2026
William Blair Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating Market news · 14 Aug 2026
Barclays Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $75 Market news · 12 Aug 2026